The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm
暂无分享,去创建一个
K Sandvik | L H Vorland | H Ulvatne | H. Ulvatne | L. Vorland | H. Haukland | K. Sandvik | H H Haukland | Hilde Ulvatne
[1] M. Zasloff,et al. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .
[2] Ø. Rekdal,et al. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. , 1999, Scandinavian journal of infectious diseases.
[3] Y. Shai,et al. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. , 1995, Biochemistry.
[4] E Maier,et al. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. , 1999, Biochemistry.
[5] I. Shalit,et al. All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance , 1990, FEBS letters.
[6] H. Ulvatne,et al. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli. , 2001, Scandinavian journal of infectious diseases.
[7] T. Gutteberg,et al. Antibacterial effects of lactoferricin B. , 1999, Scandinavian journal of infectious diseases.
[8] V. Mutt,et al. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[9] H. Ostolaza,et al. Permeabilizing action of an antimicrobial lactoferricin‐derived peptide on bacterial and artificial membranes , 1999, FEBS letters.
[10] C. B. Park,et al. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] Ø. Olsvik,et al. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes , 2001, FEBS letters.
[12] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[13] K. Yamauchi,et al. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. , 1991, Journal of dairy science.
[14] Ø. Rekdal,et al. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. , 1998, Scandinavian journal of infectious diseases.
[15] K. Matsuzaki,et al. Magainins as paradigm for the mode of action of pore forming polypeptides. , 1998, Biochimica et biophysica acta.
[16] M. Tomita,et al. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. , 1992, The Journal of applied bacteriology.
[17] A. Waring,et al. Membrane thinning effect of the beta-sheet antimicrobial protegrin. , 2000, Biochemistry.
[18] R. B. Merrifield,et al. All-D amino acid-containing channel-forming antibiotic peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. G. Boman,et al. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine , 1993, Infection and immunity.
[20] W. Shafer,et al. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Subbalakshmi,et al. Mechanism of antimicrobial action of indolicidin. , 1998, FEMS microbiology letters.